标题
Molecular Mechanisms of Chemotherapy Resistance in Head and Neck Cancers
作者
关键词
-
出版物
Frontiers in Oncology
Volume 11, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2021-05-07
DOI
10.3389/fonc.2021.640392
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Wnt signaling in cancer: therapeutic targeting of Wnt signaling beyond β-catenin and the destruction complex
- (2020) Youn-Sang Jung et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- Long Non-Coding RNA DLEU1 Up-Regulates BIRC6 Expression by Competitively Sponging miR-381-3p to Promote Cisplatin Resistance in Nasopharyngeal Carcinoma
- (2020) Hangbo Li et al. OncoTargets and Therapy
- Debio 1143 and high-dose cisplatin chemoradiotherapy in high-risk locoregionally advanced squamous cell carcinoma of the head and neck: a double-blind, multicentre, randomised, phase 2 study
- (2020) Xu-Shan Sun et al. LANCET ONCOLOGY
- Head and neck squamous cell carcinoma
- (2020) Daniel E. Johnson et al. Nature Reviews Disease Primers
- Regulation of cisplatin-resistant head and neck squamous cell carcinoma by the SRC/ETS-1 signaling pathway
- (2019) Zejia Yang et al. BMC CANCER
- Maintenance Defactinib Versus Placebo After First-Line Chemotherapy in Patients With Merlin-Stratified Pleural Mesothelioma: COMMAND—A Double-Blind, Randomized, Phase II Study
- (2019) Dean A. Fennell et al. JOURNAL OF CLINICAL ONCOLOGY
- Cancer Stem Cells in Head and Neck Squamous Cell Carcinoma: Identification, Characterization and Clinical Implications
- (2019) Peitzsch et al. Cancers
- New Insights into Mechanisms of Cisplatin Resistance: From Tumor Cell to Microenvironment
- (2019) Shang-Hung Chen et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- FAK activity sustains intrinsic and acquired ovarian cancer resistance to platinum chemotherapy
- (2019) Carlos J Diaz Osterman et al. eLife
- Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
- (2019) Barbara Burtness et al. LANCET
- A view on drug resistance in cancer
- (2019) Neil Vasan et al. NATURE
- Nivolumab vs investigator’s choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression
- (2018) Robert L. Ferris et al. ORAL ONCOLOGY
- Effect of FAK inhibitor VS-6063 (defactinib) on docetaxel efficacy in prostate cancer
- (2018) Hui-Ming Lin et al. PROSTATE
- Apoptosis-sensitizing activity of birinapant in head and neck squamous cell carcinoma cell lines
- (2018) Roman Brands et al. Oncology Letters
- Nuclear FAK and its kinase activity regulate VEGFR2 transcription in angiogenesis of adult mice
- (2018) Shaogang Sun et al. Scientific Reports
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- DNA repair pathways and cisplatin resistance: an intimate relationship
- (2018) CR Rocha et al. Clinics
- DEBIO 1143, an IAP inhibitor, reverses carboplatin resistance in ovarian cancer cells and triggers apoptotic or necroptotic cell death
- (2018) Benoît Thibault et al. Scientific Reports
- High-level βIII-tubulin overexpression occurs in most head and neck cancers but is unrelated to clinical outcome
- (2017) Julie C. Nienstedt et al. JOURNAL OF ORAL PATHOLOGY & MEDICINE
- Livin enhances chemoresistance in head and neck squamous cell carcinoma
- (2017) Tae Mi Yoon et al. ONCOLOGY REPORTS
- A New View of Pathway-Driven Drug Resistance in Tumor Proliferation
- (2017) Ruth Nussinov et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- BST2 confers cisplatin resistance via NF-κB signaling in nasopharyngeal cancer
- (2017) Chun-mei Kuang et al. Cell Death & Disease
- The FOXM1–ABCC5 axis contributes to paclitaxel resistance in nasopharyngeal carcinoma cells
- (2017) Youxiang Hou et al. Cell Death & Disease
- Role of β-catenin in cisplatin resistance, relapse and prognosis of head and neck squamous cell carcinoma
- (2017) Souvick Roy et al. CELLULAR ONCOLOGY
- RSF1 regulates the proliferation and paclitaxel resistance via modulating NF-κB signaling pathway in nasopharyngeal carcinoma
- (2017) Yong Liu et al. Journal of Cancer
- Cisplatin Alters Antitumor Immunity and Synergizes with PD-1/PD-L1 Inhibition in Head and Neck Squamous Cell Carcinoma
- (2017) Linda Tran et al. Cancer Immunology Research
- Head and Neck Cancers, Version 2.2014
- (2017) David G. Pfister et al. Journal of the National Comprehensive Cancer Network
- Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 100 randomized trials and 19,248 patients, on behalf of MACH-NC group
- (2016) P. Blanchard et al. ANNALS OF ONCOLOGY
- Expression and clinical significance of Apollon in esophageal squamous cell carcinoma
- (2016) Rong Li et al. Molecular Medicine Reports
- Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
- (2016) Robert L. Ferris et al. NEW ENGLAND JOURNAL OF MEDICINE
- Overexpression ofβ-Catenin Induces Cisplatin Resistance in Oral Squamous Cell Carcinoma
- (2016) Long Li et al. Biomed Research International
- 5-Fluorouracil upregulates cell surface B7-H1 (PD-L1) expression in gastrointestinal cancers
- (2016) Lauren Van Der Kraak et al. Journal for ImmunoTherapy of Cancer
- Chemotherapy Induces Programmed Cell Death-Ligand 1 Overexpression via the Nuclear Factor- B to Foster an Immunosuppressive Tumor Microenvironment in Ovarian Cancer
- (2015) J. Peng et al. CANCER RESEARCH
- Inhibition of the ERCC1–XPF structure-specific endonuclease to overcome cancer chemoresistance
- (2015) Ewan M. McNeil et al. DNA REPAIR
- Establishment and characterization of triple drug resistant head and neck squamous cell carcinoma cell lines
- (2015) SINDHU VALIYAVEEDAN GOVINDAN et al. Molecular Medicine Reports
- ERCC1 plays an important role in predicting survival outcomes and treatment response for patients with HNSCC: A meta-analysis
- (2015) Ma Xuelei et al. ORAL ONCOLOGY
- EGFR and NF-κB: partners in cancer
- (2015) Kateryna Shostak et al. TRENDS IN MOLECULAR MEDICINE
- A 3′-UTR KRAS-variant is associated with cisplatin resistance in patients with recurrent and/or metastatic head and neck squamous cell carcinoma
- (2014) C. H. Chung et al. ANNALS OF ONCOLOGY
- Phase II study of bevacizumab in combination with docetaxel and radiation in locally advanced squamous cell carcinoma of the head and neck
- (2014) Min Yao et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Wnt/β-catenin signalling maintains self-renewal and tumourigenicity of head and neck squamous cell carcinoma stem-like cells by activating Oct4
- (2014) Sang Hyuk Lee et al. JOURNAL OF PATHOLOGY
- Association of Drug Transporter Expression with Mortality and Progression-Free Survival in Stage IV Head and Neck Squamous Cell Carcinoma
- (2014) Rolf Warta et al. PLoS One
- Systems biology of cisplatin resistance: past, present and future
- (2014) L Galluzzi et al. Cell Death & Disease
- Inhibition of Wnt/β-catenin signaling downregulates P-glycoprotein and reverses multi-drug resistance of cholangiocarcinoma
- (2013) Dong-Yan Shen et al. CANCER SCIENCE
- Phase II study of sorafenib in combination with cisplatin and 5-fluorouracil to treat recurrent or metastatic nasopharyngeal carcinoma†
- (2012) C. Xue et al. ANNALS OF ONCOLOGY
- A phase 2 study of bevacizumab with cisplatin plus intensity-modulated radiation therapy for stage III/IVB head and neck squamous cell cancer
- (2012) Matthew G. Fury et al. CANCER
- FoxM1 and Wnt/ -Catenin Signaling in Glioma Stem Cells
- (2012) A. Gong et al. CANCER RESEARCH
- All-trans-retinoic acid inhibits growth of head and neck cancer stem cells by suppression of Wnt/β-catenin pathway
- (2012) Young Chang Lim et al. EUROPEAN JOURNAL OF CANCER
- Targeting IAP proteins for therapeutic intervention in cancer
- (2012) Simone Fulda et al. NATURE REVIEWS DRUG DISCOVERY
- XIAP Is a Predictor of Cisplatin-Based Chemotherapy Response and Prognosis for Patients with Advanced Head and Neck Cancer
- (2012) Xi-Hu Yang et al. PLoS One
- Multimodality Molecular Imaging of Apoptosis in Oncology
- (2011) Francis G. Blankenberg et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- ETS1 promotes chemoresistance and invasion of paclitaxel-resistant, hormone-refractory PC3 prostate cancer cells by up-regulating MDR1 and MMP9 expression
- (2011) Taku Kato et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Overexpression of cIAP2 contributes to 5-FU resistance and a poor prognosis in oral squamous cell carcinoma
- (2011) M Nagata et al. BRITISH JOURNAL OF CANCER
- The expression and significance of MRP1, LRP, TOPOIIβ, and BCL2 in tongue squamous cell carcinoma
- (2011) Bin Zhang et al. JOURNAL OF ORAL PATHOLOGY & MEDICINE
- High ERCC1 expression predicts cisplatin-based chemotherapy resistance and poor outcome in unresectable squamous cell carcinoma of head and neck in a betel-chewing area
- (2011) Tai-Jan Chiu et al. Journal of Translational Medicine
- Molecular mechanisms of cisplatin resistance
- (2011) L Galluzzi et al. ONCOGENE
- Oxaliplatin-mediated Inhibition of Survivin Increases Sensitivity of Head and Neck Squamous Cell Carcinoma Cell Lines to Paclitaxel
- (2010) Z. Khan et al. CURRENT CANCER DRUG TARGETS
- Focal adhesion kinase and p53 signal transduction pathways in cancer
- (2010) Vita et al. Frontiers in Bioscience-Landmark
- Paclitaxel-Dependent Cell Lines Reveal a Novel Drug Activity
- (2010) A. Ganguly et al. MOLECULAR CANCER THERAPEUTICS
- Cancer stem cell traits in squamospheres derived from primary head and neck squamous cell carcinomas
- (2010) Young Chang Lim et al. ORAL ONCOLOGY
- Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases
- (2009) Bryan T. MacDonald et al. DEVELOPMENTAL CELL
- Targeting focal adhesion kinase signaling in tumor growth and metastasis
- (2009) Joerg Schwock et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Mechanisms of tumor resistance to EGFR-targeted therapies
- (2009) Elizabeth A Hopper-Borge et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Detection of survivin and p53 in human oral cancer: Correlation with clinicopathologic findings
- (2009) Zakir Khan et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients
- (2009) Jean-Pierre Pignon et al. RADIOTHERAPY AND ONCOLOGY
- ERCC1 expression as a predictive marker of squamous cell carcinoma of the head and neck treated with cisplatin-based concurrent chemoradiation
- (2008) H J Jun et al. BRITISH JOURNAL OF CANCER
- Participation of DNA repair in the response to 5-fluorouracil
- (2008) M. D. Wyatt et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Survivin: Key Regulator of Mitosis and Apoptosis and Novel Target for Cancer Therapeutics
- (2008) A. C. Mita et al. CLINICAL CANCER RESEARCH
- Microtubules do not promote mitotic slippage when the spindle assembly checkpoint cannot be satisfied
- (2008) Daniela A. Brito et al. JOURNAL OF CELL BIOLOGY
- Cancer Stem Cells in Head and Neck Squamous Cell Cancer
- (2008) Mark E.P. Prince et al. JOURNAL OF CLINICAL ONCOLOGY
- 5-Fluorouracil: Mechanisms of Resistance and Reversal Strategies
- (2008) Ning Zhang et al. MOLECULES
- Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer
- (2008) Jan B. Vermorken et al. NEW ENGLAND JOURNAL OF MEDICINE
- IAP-targeted therapies for cancer
- (2008) E C LaCasse et al. ONCOGENE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now